Professor’s Georgina Long and Richard Scolyer are well known in the academic community and beloved by their patients. But we wanted to chat with them to get to know our new Conjoint Medical Directors a little more and find out how they plan on making an impact on melanoma.
Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.
A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.
There is emerging evidence that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.